IDH2 and Dravet syndrome: Discontinuation of the IDH inhibitor in the setting of a severe IDH-DS is often recommended, however the half-life of the IDH inhibitors is measured in days (not hours) and thus the primary treatment of IDH-DS should be with corticosteroids (dexamethasone 10 mg BID typically recommended) with supportive care as also required.